Psychology & health · 2025
The role of psychological factors in patients' choices to see their general practitioner or pharmacist for minor conditions.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Prestwich Andrew, Gerrard Emma, Panniker Kate
Аннотация
OBJECTIVE: UK-based patients can consult with, and be treated by, pharmacists for various minor medical conditions. However, research needs to identify the psychological factors that influence patients' decisions to consult with a pharmacist over alternative treatment responses. The current study addressed this gap.
METHODS AND MEASURES: UK residents (N = 329) completed measures of respect and trust for general practitioners (GPs) and pharmacists, alongside other measures that could influence treatment choices. Participants then read vignettes describing symptoms of conjunctivitis, influenza, and contact dermatitis and were asked to choose how they would respond if they experienced those symptoms.
RESULTS: Participants were nearly twice as likely to choose to see their pharmacist than GP. Respect and trust of pharmacists were higher for those choosing to see their pharmacist over those selecting treatment alternatives. GPs were respected more than pharmacists, an effect mediated by greater perceived assertiveness and morality of GPs. However, seeing pharmacists was rated less hassle and participants reported greater self-efficacy for seeing them compared to GPs.
CONCLUSION: Strategies that increase pharmacists' perceived assertiveness and morality could enhance respect and trust of pharmacists. Such changes could facilitate the current drive in the UK to utilize pharmacies more to minimise GP service demand.
METHODS AND MEASURES: UK residents (N = 329) completed measures of respect and trust for general practitioners (GPs) and pharmacists, alongside other measures that could influence treatment choices. Participants then read vignettes describing symptoms of conjunctivitis, influenza, and contact dermatitis and were asked to choose how they would respond if they experienced those symptoms.
RESULTS: Participants were nearly twice as likely to choose to see their pharmacist than GP. Respect and trust of pharmacists were higher for those choosing to see their pharmacist over those selecting treatment alternatives. GPs were respected more than pharmacists, an effect mediated by greater perceived assertiveness and morality of GPs. However, seeing pharmacists was rated less hassle and participants reported greater self-efficacy for seeing them compared to GPs.
CONCLUSION: Strategies that increase pharmacists' perceived assertiveness and morality could enhance respect and trust of pharmacists. Such changes could facilitate the current drive in the UK to utilize pharmacies more to minimise GP service demand.